At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 183 enrolled
Drug / intervention
ecabet ophthalmic solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease
In Brief
A Phase 2 clinical trial evaluating ecabet ophthalmic solution and placebo for Dry Eye Disease. Completed, enrolled 183 participants across 1 site.
Detailed Summary
Efficacy study of ecabet ophthalmic solution in dry eye disease
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Disease
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
First PostedApr 2008
Primary CompletionSep 2008
TodayJul 2026
First PostedApr 25, 2008
Enrollment StartMar 22, 2008
Primary CompletionSep 12, 2008
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 18.2 years ago
Interventions
ecabet ophthalmic solutiondrug
sterile ophthalmic solution
placebodrug
sterile ophthalmic solution